A Phase 1 Study to Investigate Safety, Tolerability, and Pharmacokinetics of CK-0045 in Healthy Participants

Condition:   Healthy Interventions:   Drug: CK-0045;   Drug: Placebo Sponsors:   Cytoki Pharma;   SGS Life Sciences, a division of SGS Belgium NV Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials